FTC goes after PBMs, warns of legal action

2 July 2022 - Last month, the Federal Trade Commission voted unanimously (5-0) to examine rising list prices of insulin, but ...

Read more →

A key precedent may sustain negotiation to keep down Medicare drug prices

1 July 2022 - Medicare drug price negotiation, which holds down prices, may emerge from the long-quiet Senate negotiations on an ...

Read more →

Drug prices make headlines again as Senate Democrats push forward pricing reforms

1 July 2022 - Senate Democrats appear to be making progress on pushing forward a set of politically popular drug pricing ...

Read more →

From FDA to MHRA: are drug regulators for hire?

29.June 2022 - Patients and doctors expect drug regulators to provide an unbiased, rigorous assessment of investigational medicines before they hit ...

Read more →

Fees and charges: summary from 1 July 2022

27 June 2022 - The TGA has updated its summary of fees and charges effective 1 July 2022. ...

Read more →

Why won’t Congress do what Mark Cuban is doing for affordable drug prices?

27 June 2022 - You’ve probably heard of Mark Cuban, billionaire co-owner of the Dallas Mavericks, serial entrepreneur and investor, and ...

Read more →

US seeks pharmaceutical deal with Switzerland to fast-track FDA approvals

27 June 2022 - The Biden administration wants to reach a narrow sectoral trade agreement with the Swiss pharmaceutical industry, ...

Read more →

Price disclosure 2022 October cycle outcomes summary

24 June 2022 - The summary of price disclosure price reductions for the 2022 October Cycle has now been published on ...

Read more →

Amryt to pursue formal dispute resolution for Oleogel-S10 (Filsuvez) NDA

24 June 2022 - Amryt today announces that the company plans to submit a formal dispute resolution request for the ...

Read more →

BioMarin announces the Ministry of Health, Labor and Welfare in Japan granted approval for Voxzogo (vosoritide) for injection for the treatment of children with achondroplasia, whose growth plates are not closed

21 June 2022 - No lower age restriction for treatment. ...

Read more →

Prescription medicines: applications under evaluation

21 June 2022 - The TGA has updated its list of applications for new medicines or new uses for existing ...

Read more →

FDA caught up on domestic pre-approval inspections, foreign inspections still a challenge

20 June 2022 - The US FDA eliminated its backlog of overdue domestic pre-approval inspections, yet such progress has been ...

Read more →

Drug pricing debate in Washington is a headache for pharma

17 June 2022 - Last-ditch effort by Democrats to pass slimmed-down version of Build Back Better could include measures on drug ...

Read more →

Klobuchar, Porter call for FTC to investigate price hikes by Janssen, Bristol Myers Squibb

14 June 2022 - Two prominent Democratic lawmakers are requesting that the Federal Trade Commission investigate whether price hikes for ...

Read more →

Canadian drug prices: new regulations could save billions of dollars

15 June 2022 - New drug price regulations set to come into effect next month could lower spending on patented ...

Read more →